Study Summary
This trial will study how our bodies respond to the flu, and how the virus is transmitted. They will use a safe, controlled form of the flu virus, and expect mild to moderate symptoms.
- Influenza
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
3 Primary · 3 Secondary · Reporting Duration: Baseline, Day 28
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Influenza Challenge Model with Influenza A H3N2 Strain
1 of 1
Experimental Treatment
10 Total Participants · 1 Treatment Group
Primary Treatment: Influenza Virus Type A H3N2 Challenge · No Placebo Group · Phase 1
Trial Logistics
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 49 · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Georgia | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| Emory University Hospital | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Frequently Asked Questions
Is it feasible for those aged 75 and above to participate in the experiment?
"This trial is open to those aged between 18 and 49. All participants must fall within this age range in order meet the stipulated criteria for enrollment." - Anonymous Online Contributor
Are participants still being accepted for this investigation?
"According to clinicaltrials.gov, this experimental medical trial has begun recruiting participants since it was posted on the 24th of May 2022 and recently updated on 27th June 20202." - Anonymous Online Contributor
Am I eligible to partake in this clinical experiment?
"This clinical trial is recruiting 10 individuals between the ages 18 and 49 who are presently suffering from influenza. To be eligible, one must also meet several criteria such as: abstaining or using birth control for 30 days prior to enrollment; male subjects refraining from fathering a child during the trial; being healthy enough to comprehend and adhere to study procedures; having no cardiovascular disease, chronic medical conditions requiring close follow-up in past 5 years, neurological/neurodevelopmental illnesses, nor chronic pulmonary diseases (e.g., asthma). Additionally, women of childbearing potential must have negative pregnancy tests at screening and within 24 hours before challenge." - Anonymous Online Contributor
How many people have been recruited thus far to participate in this investigation?
"Correct. According to records on clinicaltrials.gov, this medical experiment is still in need of participants since its initial posting on May 24th 2022 and last logging update on June 27th 2022. 10 test subjects are needed from 3 different locations." - Anonymous Online Contributor